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Congenital heart disease is estimated to occur in 8 to 9
cases per 1,000 live births [1,2]. Among them, congen-
ital cardiac tumors are estimated to occur in 1–2 per
10,000 patients, and over 90% of these are benign [3–5].
Hence, congenital cardiac tumors account for most
sonographic cardiac abnormalities.
Of these congenital cardiac tumors, rhabdomyoma
is the most common, accounting for up to 60% of all
fetal cardiac lesions [6]. It may occur as a single lesion
or as multiple lesions, usually within the ventricles. Con-
genital cardiac rhabdomyoma tumors are often visual-
ized by echocardiography as a pedunculated mass that
may obstruct ventricular flow.
There is a very strong association between fetal car-
diac rhabdomyomas and tuberous sclerosis. Around
50% to 80% of fetuses with rhabdomyomas have tuber-
ous sclerosis [7,8]. In addition, this cardiac tumor is
the commonest childhood cardiac neoplasm and is
almost always multiple and ventricular [9]. Its presence
increases the frequency of mental retardation and con-
vulsions by up to 80%. The diagnosis of intrauterine
tuberous sclerosis is, however, difficult. Definitive ante-
natal diagnosis using DNA probes or linked markers
may be useful, but such examinations are usually not
available in most hospitals. Therefore, prenatal diag-
nosis is usually based on appropriate family history and
visualization of characteristic tumors on fetal cardiac
sonography [9,10].
We present an interesting case of fetal multiple lesion-
type congenital myocardial rhabdomyomas and a review
of the literature. This report presents data, including
sonographic images, autopsy report and chromosome
studies, that may add further insight into this rare fetal
tumor.
A 25-year-old, gravida 1, para 0, patient had an un-
remarkable antenatal history, including the first-trimester
triple test and nuchal translucency. Amniocentesis was
performed at 16 weeks and revealed a 46,XY karyotype.
There were no significant findings in the patient’s past
medical, surgical or family history. Most importantly,
there was no family history of tuberous sclerosis.
At 29 weeks, sonographic evaluation of the fetus
revealed symmetrical biometric measurements of the
fetal head, abdomen and long bones that were con-
sistent with the estimated gestational age. However,
fetal echocardiography revealed a homogeneous, solid,
echogenic mass measuring 8 × 6 mm within the left
ventricle (Figure 1). The heart rhythm was normal. There
was no evidence of pericardial effusion or ascites. Fetal
aortic and umbilical artery Doppler studies were appro-
priate for the gestational age. Intracranial and renal
anatomies were unremarkable. Hence, cardiac rhabdo-
myoma was suspected on the grounds of the intracardiac
sonographic finding.
The patient was followed closely. Intrauterine fetal
death was discovered 1 week later without signs of
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Figure 1. Rhabdomyoma (arrow) measuring 8 × 6 mm within
the left ventricle.
abdominal pain or vaginal bleeding. The pregnancy was
medically terminated using intravaginal misoprostol.
A dead fetus was delivered 12 hours later. Gross exami-
nation revealed generalized ecchymosis with mild ede-
matous change of the umbilical cord (Figure 2). No
other gross abnormalities were noted.
Upon the patient’s consent for fetal autopsy, the
procedure was performed with autopsy results confirm-
ing our diagnosis of multiple intracardiac rhabdomy-
omas (Figures 3–6). No other renal or brain tumors
were found.
The differential diagnosis of a fetal intracardiac tumor
should include that of rhabdomyoma, teratoma, sar-
coma, myxoma, and fibroma. Rhabdomyoma is by far
the commonest and accounts for up to 60% of all
intracardiac tumors. Rhabdomyomas are often multi-
ple, well-circumscribed tumors that can occur any-
where in the myocardium. They may originate from the
atria or the free wall of the ventricular myocardium,
but most frequently originate from the ventricular sep-
tum. Tumor size is variable, with some tumors being
only a few millimeters in diameter. The clinical presen-
tation of intracardiac rhabdomyomas depends on their
number, size, and position. Their presentation ranges
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Figure 2. Ecchymosis and mild edematous change of the
umbilical cord.
Figure 3. The absence of intracardiac tumor on autopsy.
Figure 4. Multiple nodular lesions of varying sizes (arrows)
within the myocardium (hematoxylin and eosin, original
magnification).
Figure 6. Vacuolated rhabdomyoma cells of varying sizes
with characteristic spider appearance (arrow; hematoxylin
and eosin, ×400).
Figure 5. Nest of pale rhabdomyoma cells in the myometrium
(hematoxylin and eosin, ×100).
from symptom-free, congestive cardiac failure, low car-
diac output secondary to intracardiac flow obstruction,
and arrhythmias, to sudden death.
Tuberous sclerosis is an autosomal dominant dis-
order complex characterized by the development of
distinctive benign tumors in multiple organ systems,
including the skin, brain, heart, lungs, kidney and liver
[11]. Mutations in at least two different genes have
been identified. One such gene is located on chromo-
some 9 (TSC1) and the other on chromosome 16 (TSC2).
The TSC1 gene, mapped to chromosome 9q34, has 
21 coding exons and two leader exons, and encodes a
130 kDa (1,164 amino acids) protein named hamartin.
The TSC2 gene, mapped to chromosome 16p13.3, has
41 coding exons and one leader exon, and encodes a
198 kDa (1,807 amino acids) protein named tuberin
[11]. TSC2 mutations are more common (70%) than
TSC1 mutations (30%). Furthermore, approximately
70% of the mutations are de novo [12].
It is estimated that 50–86% of those affected with
tuberous sclerosis have rhabdomyomas [13,14]. Rhab-
domyomas are usually small, multiple (> 90%), miliary
nodules measuring less than 1 mm. Hence, a search for
these extracardiac hamartomas should be performed
in all cases of intracardiac tumors.
Crawford et al suggested that the presence of intra-
cardiac rhabdomyomas can help identify tuberous scle-
rosis on an antenatal basis [15]. Subsequently, other
investigators confirmed that the prenatal diagnosis 
of intracardiac rhabdomyomas is preliminary evidence
that the fetus will have other postnatal manifestations
of tuberous sclerosis. However, many tuberous sclero-
sis cases are results of de novo mutations, making a
diagnosis based on family history unproductive.
Most fetuses with intracardiac rhabdomyomas asso-
ciated with tuberous sclerosis are asymptomatic. Occa-
sional arrhythmias may be detected by fetal heart rate
monitoring [5]. After birth, the outcome of intracar-
diac rhabdomyomas remains uncertain. Some series
suggested a poor outcome with a high mortality rate
[16–18]. Recent reports have described spontaneous
regression of these tumors [19–24]. In a fetus with an
intracardiac rhabdomyoma, serial sonographic evalu-
ation is indicated to determine the presence of fetal
cardiac decompensation and fetal hydrops. A careful
family history may reveal tuberous sclerosis, if this disease
is not already obvious in the index case. Appropriate
genetic counseling should be offered to the parturient
patient and other family members. The absence of a fam-
ily history does not exclude tuberous sclerosis in the fetus,
as many cases represent de novo mutations. Delivery of
the neonate not presenting with significant hemody-
namic compromise should be managed expectantly and
monitored for tumor regression. Serial sonographic eval-
uation and magnetic resonance imaging can be used;
in some cases, angiography may be indicated. Surgery
is often not necessary, even with massive tumor size, 
as tumor regression has been documented [19–24].
However, when cardiac outflow obstruction, persistent
arrhythmias, cardiac failure or cardiogenic emboli are
present, surgical resection may be lifesaving [17–19].
Delivery at a tertiary institution complete with pediatric
cardiology and surgery services is recommended.
In conclusion, we have presented a case of fetal
intracardiac rhabdomyoma and reviewed the litera-
ture. Intracardiac rhabdomyoma is closely associated
with tuberous sclerosis. When an intracardiac tumor 
is detected prenatally, hamartomas should be looked
for in other organs. Magnetic resonance imaging may
help delineate other fetal hamartomas, especially those
originating from the brain and kidney. In addition,
amniocentesis for chromosome karyotype and cordo-
centesis for specific DNA probe examination may be
arranged.
In our case, the intracardiac rhabdomyoma was
detected by sonography without the presence of other
hamartomas. The patient was regularly followed for
fetal cardiac outflow obstruction and arrhythmia. Mag-
netic resonance was not arranged in time before fetal
death. Cordocentesis can detect the presence of TSC1
and TSC2 gene mutations using specific DNA probes.
As the fetus did not have multiple organ hamartomas
and intracardiac rhabdomyomas often regress after
birth, serial sonography was preferred over the more
invasive cordocentesis.
Fetal autopsy revealed that the intracardiac rhab-
domyomas were of multiple nodular type, though these
lesions were not grossly evident on autopsy. This find-
ing was not compatible with the prenatal sonographic
finding of a single intraventricular mass. This feature
was seen in our case as a solitary sonographic intracar-
diac tumor and turned out instead to be multi-lesional.
In addition, multiple intracardiac rhabdomyomas are
often only associated with those affected with tuberous
sclerosis, which was not true in our case. Altogether, the
value of performing magnetic resonance imaging in
delineating multi-lesion rhabdomyomas is questionable.
Multiple miliary intracardiac rhabdomyomas were
the only finding upon pathology. Although rhabdomy-
oma may lead to cardiac outflow obstruction, this was
not likely to be the cause of fetal death in our case, as
the grossly non-evident tumors were not large enough
to lead to cardiac outflow obstruction. Arrhythmia is
another complication of an intracardiac rhabdomy-
oma. We suspect that fetal death was the result of
arrhythmia.
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Cord accident may often be the cause of sudden
intrauterine fetal death. Ecchymosis of the umbilical
cord with mild edematous change may be compatible
with cord accident. Thus, cord accident may well be
another possibility of the fetal death.
To conclude, fetal intracardiac tumors are rare and
should be cared for in a tertiary institution. Close ante-
natal follow-up may help reduce morbidity and mortal-
ity. Pediatric cardiologists and cardiovascular surgeons
can offer further care and emergent surgical manage-
ment should the fetus survive to term.
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